The China genetic testing market size reached US$ 4.3 billion in 2023. The market is projected to reach US$ 14.9 billion by 2032, exhibiting a growth rate (CAGR) of 14.9% during 2023-2032.
Genetic testing, also known as DNA testing, provides the determination of bloodlines and the genetic diagnosis of vulnerabilities to diseases that can be inherited. It determines changes in chromosomes, genes, or proteins. The results obtained from a genetic test can confirm or rule out a suspected genetic disorder or help identify a person’s chance of developing or passing on a genetic disorder. Genetic testing is becoming popular in China. It may benefit many different interest groups, such as individuals and families with a history of genetic disorder, pregnant women, employers, and health or life insurance. This market is currently driven by a number of factors such as rising awareness regarding the benefits of genetic testing, availability of direct to consumer tests and increasing incidences of genetic disorders.
Over the past few years, there has been a significant rise in the awareness levels regarding the benefits of genetic testing in China. Genetic testing provides various technologies that help in the early detection of various chronic diseases and ensures its treatment and prevention. Moreover, a rise in the availability of Direct to consumer tests (DTC) which has increased the convenience and accessibility of such tests is also creating a positive impact in the growth of the market. Moreover, In October, 2015, China announced that the iconic one-child policy had finally been replaced by a universal two-child policy. This is expected to increase the number of babies born each year and create a positive impact on the demand of the new born genetic testing segment. Other major factors that are expected to drive this market include growing middle class, aging population, and expanding healthcare system.
2. What is the expected growth rate of the China genetic testing market during 2024-2032?
3. What are the key factors driving the China genetic testing market?
4. What has been the impact of COVID-19 on the China genetic testing market?
5. What is the breakup of the China genetic testing market based on the test type?
6. What is the breakup of the China genetic testing market based on the disease?
7. What is the breakup of the China genetic testing market based on technology?
8. What is the breakup of the China genetic testing market based on the service provider?
9. What is the breakup of the China genetic testing market based on the testing sample?
10. Who are the key players/companies in the China genetic testing market?
Genetic testing, also known as DNA testing, provides the determination of bloodlines and the genetic diagnosis of vulnerabilities to diseases that can be inherited. It determines changes in chromosomes, genes, or proteins. The results obtained from a genetic test can confirm or rule out a suspected genetic disorder or help identify a person’s chance of developing or passing on a genetic disorder. Genetic testing is becoming popular in China. It may benefit many different interest groups, such as individuals and families with a history of genetic disorder, pregnant women, employers, and health or life insurance. This market is currently driven by a number of factors such as rising awareness regarding the benefits of genetic testing, availability of direct to consumer tests and increasing incidences of genetic disorders.
Over the past few years, there has been a significant rise in the awareness levels regarding the benefits of genetic testing in China. Genetic testing provides various technologies that help in the early detection of various chronic diseases and ensures its treatment and prevention. Moreover, a rise in the availability of Direct to consumer tests (DTC) which has increased the convenience and accessibility of such tests is also creating a positive impact in the growth of the market. Moreover, In October, 2015, China announced that the iconic one-child policy had finally been replaced by a universal two-child policy. This is expected to increase the number of babies born each year and create a positive impact on the demand of the new born genetic testing segment. Other major factors that are expected to drive this market include growing middle class, aging population, and expanding healthcare system.
Key Market Segmentation:
The report provides an analysis of the key trends in each sub-segment of the China genetic testing market report, along with forecasts for the period 2023-2032. The report has categorized the market based on test type, disease, technology, service provider and testing sample.Breakup by Test Type:
- Prenatal Testing
- Carrier Testing
- New Born Testing
- Predictive/Presymptomatic Testing
- Diagnostic Testing
- Others
Breakup by Disease:
- Cancer
- Down Syndrome
- Thalassemia
- Others
Breakup by Technology:
- Biochemical
- Molecular
- Cytogenetic
Breakup by Service Provider:
- Hospital Based Laboratories
- Independent Laboratories
- Specialty Clinics
Breakup by Testing Sample:
- Blood
- Saliva
- Hair
- Others
Competitive Landscape
The report has also examined the competitive landscape of the China genetic testing market. Some of the major players include:- BGI
- Berry Genomics Co. ltd.
- Daan Gene Co. Ltd
- WuXi NextCODE
- Annoroad Gene Technology Co. Ltd.
- WuXi PharmaTech
Key Questions Answered in This Report
1. What was the size of the China genetic testing market in 2023?2. What is the expected growth rate of the China genetic testing market during 2024-2032?
3. What are the key factors driving the China genetic testing market?
4. What has been the impact of COVID-19 on the China genetic testing market?
5. What is the breakup of the China genetic testing market based on the test type?
6. What is the breakup of the China genetic testing market based on the disease?
7. What is the breakup of the China genetic testing market based on technology?
8. What is the breakup of the China genetic testing market based on the service provider?
9. What is the breakup of the China genetic testing market based on the testing sample?
10. Who are the key players/companies in the China genetic testing market?
Table of Contents
1 Preface3 Executive Summary
2 Scope and Methodology
4 Introduction
5 China Genetic Testing Market
6 Market Breakup by Test Type
7 Market Breakup by Disease
8 Market Breakup by Technology
9 Market Breakup by Service Provider
10 Market Breakup by Testing Sample
11 Competitive Landscape
12 Key Player Profiles
List of Figures
List of Tables
Companies Mentioned
- BGI
- Berry Genomics Co. ltd.
- Daan Gene Co. Ltd
- WuXi NextCODE
- Annoroad Gene Technology Co. Ltd.
- WuXi PharmaTech
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 118 |
| Published | January 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 4.3 Billion |
| Forecasted Market Value ( USD | $ 14.9 Billion |
| Compound Annual Growth Rate | 14.9% |
| Regions Covered | China |
| No. of Companies Mentioned | 6 |
